Regencell Bioscience (RGC) had the highest return between January 2, 2025 and May 5, 2025 by a US stock with a market cap of $2B+, returning 1,729.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Regencell Bioscience (RGC) | 1/2/2025 - 5/5/2025 | 1,729.49% |
TMC the metals (TMC) | 1/2/2025 - 5/5/2025 | 173.68% |
Orla Mining (ORLA) | 1/2/2025 - 5/5/2025 | 91.46% |
Harmony Gold Mining (HMY) | 1/2/2025 - 5/5/2025 | 90.6% |
AngloGold Ashanti (AU) | 1/2/2025 - 5/5/2025 | 81.51% |
Forward Industries (FORD) | 1/2/2025 - 5/5/2025 | 81.22% |
Xpeng (XPEV) | 1/2/2025 - 5/5/2025 | 72.34% |
Soleno Therapeutics (SLNO) | 1/2/2025 - 5/5/2025 | 70.74% |
Hims Hers Health (HIMS) | 1/2/2025 - 5/5/2025 | 70.11% |
IHS (IHS) | 1/2/2025 - 5/5/2025 | 69.86% |
Gold Fields Ltd ADR (GFI) | 1/2/2025 - 5/5/2025 | 68.97% |
Hertz Global (HTZ) | 1/2/2025 - 5/5/2025 | 67.12% |
DRDGOLD Limited ADR (DRD) | 1/2/2025 - 5/5/2025 | 66.13% |
StoneCo (STNE) | 1/2/2025 - 5/5/2025 | 65.3% |
Adaptive Biotechnologies (ADPT) | 1/2/2025 - 5/5/2025 | 64.7% |
Banco Santander SA ADR (SAN) | 1/2/2025 - 5/5/2025 | 62.94% |
Palantir Technologies Inc Class A Common Stock (PLTR) | 1/2/2025 - 5/5/2025 | 62.43% |
Inter & Co Inc Class A Common Shares (INTR) | 1/2/2025 - 5/5/2025 | 62.42% |
Akero Therapeutics (AKRO) | 1/2/2025 - 5/5/2025 | 59.97% |
Tempus AI, Inc Class A Common Stock (TEM) | 1/2/2025 - 5/5/2025 | 59.55% |
MP Materials (MP) | 1/2/2025 - 5/5/2025 | 58.99% |
Deutsche Bank (DB) | 1/2/2025 - 5/5/2025 | 56.92% |
New Gold (NGD) | 1/2/2025 - 5/5/2025 | 56.57% |
Grupo Cibest (CIB) | 1/2/2025 - 5/5/2025 | 56.47% |
Summit Therapeutics (SMMT) | 1/2/2025 - 5/5/2025 | 55.93% |
